Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Health Care · ·
$37.58
▼ $0.03 (-0.1%)
Market data updated: 09/30 09:10 PM
Fundamentals updated: 09/30/2026
News analyzed: 09/30/2026
Market Cap
$1.81B
Day Range
$37.20 - $38.05
52-Week Range
$24.95 - $44.39
Beta
—
Next Earnings
09.11.2026
Support
$36.90
Resistance
$44.39
SNDA is a stock from the Healthcare sector — Pharmaceuticals, biotech, medical devices, and health insurance — less sensitive to economic cycles, but exposed to regulation and FDA approvals.
+35.6% (1Y)
Strengths: 7/29 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Revenue growth (last year)
Revenue growth (last year): 25.2%
Growth
Biggest negative driver
DCF Fair Value
Estimated fair value: -$48.25 vs. price $37.58 (-228.4%)
Fair Value
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 3 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 3
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
46
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
54
Quality
47
Value
38
Momentum
23
Risk
48
Sentiment
100
Fundamental
45
Institutional
0
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Sonida Senior Living, Inc. (SNDA) has centered on analyst upgrades and price target adjustments, reflecting optimism about its growth prospects. Baird upgraded the stock to "Outperform" with a raised price target to $43, while Morgan Stanley increased its target to $44, citing strong senior housing occupancy as a key growth driver. Insider selling activity and broader sector trends in senior living REITs also drew attention, though no major operational or financial surprises were highlighted.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Sonida Senior Living, Inc.. News trend score: 100. Reason: 15 of the last 20 articles are positive, versus 1 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
18
🎯 Conviction (vs. Emotion)
38
Psychology
64
Fundamentals
45
Technical
23
Valuation
38
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
A significant decline over time, but on unusually low trading volume — holders unwilling to accept the loss.
Extreme momentum, price far above its moving average, and a large premium over fair value.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
Price (3M)
-11%
Market Narrative
58
Fundamental Reality
38
Narrative Gap
+20
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
Market behavior suggests a detached euphoria driven by perfect news sentiment and a slight outperformance above the 200-day average, despite weak momentum. Overconfidence is elevated as price momentum exceeds declining fundamentals, while anchoring to support keeps sellers cautious. The narrative gap (63 vs. 38) implies traders may be overestimating positive catalysts. The key question: will sentiment sustain momentum or collapse under negative earnings growth?
Updated: 09/08/2026, 04:10 PM
What could change this?
👥 What the crowd believes
"Baird Upgrades Sonida Senior Living to Outperform... Raises Price Target to $43 From $37"
"Occupancy surged 240 basis points as company scales hospitality-driven model"
"Updates August 17, 2026 resale registration for up to 18.7M shares"
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 90/100
🔴 Weakest match
Thorstein Veblen — 27/100
🗣️ Why do they disagree?
The methodologies here split sharply between bullish and cautious views, reflecting starkly different priorities. Samuel Armstrong Nelson and Charles Mackay’s scores near 70 suggest they’d see this stock as cyclically oversold or crowd-driven, implying a potential rebound or speculative opportunity. Meanwhile, Fisher, Housel, and Smith—all scoring in the mid-60s—view it as solid but not exceptional, leaning toward a pragmatic hold rather than a high-conviction bet. The divide widens further with Graham, Lynch, and Marks (all below 55), who flag either weak valuation, overpriced growth, or inflated expectations, while Livermore and Veblen’s low scores (39 and 27) dismiss it outright as trend-resistant or growth-chasing. Even the efficient-market camp sees no clear edge, reinforcing that this stock’s appeal hinges entirely on subjective interpretation rather than objective edge.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 90
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟢 72
The kind of quiet compounder a patient holder could actually stick with
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 69
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 63
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟡 60
Solid, but not the exceptional quality Fisher looked for
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 53
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 52
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 50
Mixed — doesn't clearly pass Graham's tests
Key question
Where is my margin of safety?
⚠️ Partial data for this stock — score is less reliable — Data availability: 30%
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 48
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 48
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟡 47
No clear edge either way
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟡 45
Mixed — growth exists but the price already reflects much of it
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 36
Liquidity position Bagehot would flag as a real risk
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🔴 34
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 27
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 0
Not enough valuation data for a real Enterprising-Graham read
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 20%
Fact → Principle → Simulation
Based on the last 288 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (1 bullish · 9 bearish · 1 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
—
Net Margin
-18.6%
EBITDA Margin
—
ROE
643445.5%
ROA
-8.4%
ROIC
—
EPS
-$4.22
Cash
$11.01M
Total Debt
$689.74M
Current Ratio
0.74
Debt/Equity
-62703.73
How is Fair Value calculated? →
Current Price
$37.58
Estimated Fair Value (DCF)
-$48.25
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-228.4%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
17.2%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 17.2% | $-10.45M | $-9.59M |
| 2 | 13.5% | $-11.86M | $-9.99M |
| 3 | 9.8% | $-13.03M | $-10.06M |
| 4 | 6.2% | $-13.83M | $-9.80M |
| 5 | 2.5% | $-14.18M | $-9.22M |
Base FCF (last actual year)
$-8.92M
Terminal Value
$-223.60M
Present Value of Terminal Value
$-145.33M
Enterprise Value
$-193.98M
Net Debt
$678.73M
Equity Value
$-872.71M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
-$0.00
Tangible Book Value per Share (Tangible NAV)
-$1.09
Sentiment based on basic keywords (not AI) — 15 positive, 4 neutral, 1 negative out of the last 20 articles.
Yahoo · 22.9.2026
Yahoo · 9.9.2026
Business Wire · 9.9.2026
SeekingAlpha · 7.9.2026
Yahoo · 6.9.2026
Simply Wall St. · 6.9.2026
Fintel · 5.9.2026
MT Newswires · 4.9.2026
MT Newswires · 4.9.2026
Yahoo · 4.9.2026
The Fly · 4.9.2026
Benzinga · 4.9.2026
Yahoo · 4.9.2026
24/7 Wall St. · 4.9.2026
MT Newswires · 4.9.2026
Benzinga · 4.9.2026
MT Newswires · 2.9.2026
Yahoo · 1.9.2026
MT Newswires · 1.9.2026
MT Newswires · 1.9.2026
Sonida Senior Living, Inc. (SNDA) currently has a StockIQ AI score of 46/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
SNDA currently scores 46/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, SNDA's estimated fair value is -$48.25, which is 228.4% below the current price of $37.58. This is one valuation model among several signals in the fair-value category, not a price target.
SNDA's technical score is 23/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Revenue growth (last year): 25.2%; Free cash flow growth: 66.9%; Return on equity (ROE): 643445.5% — strong.
Based on the real signals StockIQ computed: Estimated fair value: -$48.25 vs. price $37.58 (-228.4%); Net margin: -18.6% (negative); Operating margin is eroding over time.
StockIQ has no recorded dividend payment history for SNDA.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 16 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Simanovsky Michael | Other Transaction | 2.9.2026 | 0 | -100,373 | — |
| Simanovsky Michael | Other Transaction | 2.9.2026 | 100,373 | -100,373 | — |
| Simanovsky Michael | Open Market Sale | 1.9.2026 | 100,373 | -97,581 | $38.42 |
| Simanovsky Michael | Open Market Sale | 1.9.2026 | 97,581 | -97,581 | $38.42 |
| Simanovsky Michael | Open Market Sale | 28.8.2026 | 197,954 | -4,615 | $39.25 |
| Simanovsky Michael | Open Market Sale | 28.8.2026 | 202,569 | -21,792 | $38.16 |
| Simanovsky Michael | Open Market Sale | 28.8.2026 | 4,615 | -4,615 | $39.25 |
| Simanovsky Michael | Open Market Sale | 28.8.2026 | 21,792 | -21,792 | $38.16 |
| Simanovsky Michael | Open Market Sale | 27.8.2026 | 224,361 | -15,000 | $39.00 |
| Simanovsky Michael | Open Market Sale | 27.8.2026 | 15,000 | -15,000 | $39.00 |
| Simanovsky Michael | Open Market Sale | 26.8.2026 | 239,361 | -15,086 | $40.94 |
| Simanovsky Michael | Open Market Sale | 26.8.2026 | 15,086 | -15,086 | $40.94 |
| Simanovsky Michael | Open Market Sale | 25.8.2026 | 254,447 | -115,000 | $40.71 |
| Simanovsky Michael | Open Market Sale | 25.8.2026 | 115,000 | -115,000 | $40.71 |
| Simanovsky Michael | Other Transaction | 21.8.2026 | 652,356 | -1,182,595 | — |
| Simanovsky Michael | Other Transaction | 21.8.2026 | 1,182,595 | -1,182,595 | — |
| Harris Benjamin P | Open Market Sale | 14.8.2026 | 13,232 | -3,074 | $39.79 |
| Harris Benjamin P | Open Market Sale | 14.8.2026 | 10,037 | -3,195 | $39.79 |
| Harris Benjamin P | Open Market Sale | 14.8.2026 | 3,074 | -3,074 | $39.79 |
| Harris Benjamin P | Open Market Sale | 14.8.2026 | 3,195 | -3,195 | $39.79 |
| Simanovsky Michael | Exercise of Derivative Securities | 10.8.2026 | 6,857,823 | +1,504,134 | $32.00 |
| Simanovsky Michael | Grant/Award from Employer | 10.8.2026 | 38,742 | +38,742 | — |
| Simanovsky Michael | Disposition to the Company | 10.8.2026 | 709,744 | -97,371 | — |
| Simanovsky Michael | Exercise of Derivative Securities | 10.8.2026 | 0 | -38,742 | — |
| Simanovsky Michael | Exercise of Derivative Securities | 10.8.2026 | 807,115 | +97,371 | $32.00 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
3,549,788 shares short as of 2026-09-15 · vs. 3,367,796 on 2026-08-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
67.8% of trading volume this week was short selling, vs. 67.8% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology